Check out this:https://unauthorised investment advice/health/the-asx-small-caps-looking-to-capitalise-on-post-covid-trends-in-animal-health/Intersting to read, Layton gives us an outlook for the next time. CheersNauschder
Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market